Covalon Announces Conference Call to Discuss Q2 Financial Results
R&D investments and a narrowed focus have widened the firm's competitive advantages.
Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.
After a few fits and starts, Tyco is now set to trade under three separate tickers starting July 2. Tyco International will retain the TYC ticker, Tyco Electronics will assume the TEL ticker, and Covidien , the health-care concern, will trade as COV . We'll have a separate analyst covering each; ...
Global Digestible Sensors Market - Industry Forecast to 2025 - Driven by an Increase in the Growth of Medical Devices - Research and Markets
The device maker's planned acquisition of Covidien will make it a force to be reckoned with.
Health-care stocks are on a tear as demand slowly returns.
Morningstar StockInvestor editor Matt Coffina discusses recent additions to the Wide Moat Focus Index.
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.